Services
Genomic Testing
Companion Diagnostic Test
Laboratory Developed Tests (LDT)
Solid Tumors
Hematologic Malignancies
Hereditary Cancers
Minimal Residual Disease
RUO Kit Solution
Research Services
Platforms
DNA Sequencing
RNA Sequencing
Other Services
Technology
Our Technology
Publications
Partnerships
About Us
What is Precision Oncology?
Our Company
Our Team
Certificates & Accreditation
News
Join Us
Contact Us
Ch|中文
Search
May 25, 2023
GENESEEQ TO SHOWCASE NEW FINDINGS AT ASCO 2023
by Geneseeq
May 16, 2023
Geneseeq published new research on the clinical use of circulating-free DNA fragmentomic in monitoring minimal residual disease for patients with non-small-cell lung cancer
by Geneseeq
October 18, 2022
Geneseeq study highlights ctDNA monitoring clinical value in colorectal cancer patients resistant to BRAF/EGFR-targeted therapy
by Geneseeq
August 31, 2021
Geneseeq Study Evaluates ctDNA MRD to Predict Response to Therapy and Assess Prognosis in Locally Advanced Rectal Cancer
by Geneseeq
May 26, 2021
Geneseeq Presenting Data at the American Society of Clinical Oncology Annual Meeting 2021
by Geneseeq
Privacy Preference Center
Privacy Preferences
